Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-1111P** is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family, which are found throughout the vertebrate genome as relics of retrotransposition events[5]. While functional U6 snRNA is an essential component of the major spliceosome—a cellular complex responsible for the splicing of pre-mRNA—pseudogenes like RNU6-1111P do not encode active snRNA or have any functional activity in splicing or cellular processes[3][5]. Their presence is attributed to L1-mediated retrotransposition, a process that copies RNA sequences back into the genome, thereby creating non-functional, typically truncated, gene “copies.” These pseudogenes serve as genomic markers for retrotransposition activity and evolutionary processes but do not possess biological or therapeutic function[5]. **Key notes:** - RNU6-1111P should **not** be considered a drug target, receptor, enzyme, or disease marker. - The core U6 snRNA gene (not pseudogenes) is functionally crucial for RNA splicing, but pseudogenes like RNU6-1111P are inactive[1][3][5]. If "RNU6-1111P" is being considered as a target in any context, this is **incorrect** based on current molecular biology understanding, as it is an inactive genomic element with no known physiological or pathological function[2][4][5].
None (not a therapeutic target; no active mechanisms)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1111, pseudogene (RNU6-1111P).